Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/18/17
End: 10/15/18
Due: 10/15/19
Phase: N/A
Priority: Normal
Start: 09/20/22
End: 05/01/23
Due: 05/01/24
Phase: N/A
Priority: Normal
Start: 08/01/18
End: 07/01/23
Due: 07/01/24
Phase: N/A
Priority: Normal
Start: 08/23/18
End: 02/02/22
Due: 02/02/23
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 03/01/23
Due: 03/01/24
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Treatment of Restless Leg Syndrome (RLS) Augmentation With Ecopipam, a D1 Specific Antagonist | NCT03218969 | William Ondo, MD | user2@example.com | None | 2017-09-18 | 2018-10-15 | 2019-10-15 | - | - | 2025-07-14 |
| Pitolisant in Refractory Restless Legs Syndrome | NCT05581576 | William Ondo, MD | user2@example.com | None | 2022-09-20 | 2023-05-01 | 2024-05-01 | - | - | 2025-07-14 |
| A Pilot Study Assessing Impulsivity in Patients With Huntington's Disease on Xenazine (Tetrabenazine) | NCT02509793 | William Ondo, MD | user2@example.com | None | 2018-08-01 | 2023-07-01 | 2024-07-01 | - | - | 2025-07-14 |
| Brain Perfusion & Oxygenation in Parkinson's Disease With NOH | NCT03229174 | William Ondo, MD | user2@example.com | None | 2018-08-23 | 2022-02-02 | 2023-02-02 | - | - | 2025-07-14 |
| Sublingual Apomorphine in Refractory Restless Legs Syndrome | NCT05529095 | William Ondo, MD | user2@example.com | None | 2022-09-01 | 2023-03-01 | 2024-03-01 | - | - | 2025-07-14 |